Head and neck cancer
暂无分享,去创建一个
[1] I. Bross,et al. A study of the etiological factors in cancer of the mouth , 1957, Cancer.
[2] Pelayo Vilar,et al. Nasopharyngeal Carcinoma , 1966 .
[3] K. Rothman,et al. Epidemiology of laryngeal cancer. , 1980, Epidemiologic reviews.
[4] L. Pickle,et al. Snuff dipping and oral cancer among women in the southern United States. , 1981, The New England journal of medicine.
[5] R. Saracci. The interactions of tobacco smoking and other agents in cancer etiology. , 1987, Epidemiologic reviews.
[6] D. Winn,et al. Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.
[7] F. Berrino,et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: Iarc international case‐control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France) , 1988, International journal of cancer.
[8] R. Weichselbaum,et al. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] L J Peters,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.
[10] W. Hong,et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.
[11] L. Hutchins,et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Jacobs,et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. , 1992, International journal of radiation oncology, biology, physics.
[13] S. Schantz,et al. Hereditary and environmental factors associated with risk and progression of head and neck cancer. , 1992, Otolaryngologic clinics of North America.
[14] S. Lippman,et al. Head and Neck Cancer , 1993, Cancer treatment and research.
[15] J. Grandis,et al. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. , 1993, Cancer research.
[16] G. Browman,et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. , 1993, The New England journal of medicine.
[17] A S Garden,et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. , 1993, International journal of radiation oncology, biology, physics.
[18] E. Myers,et al. Microlaryngoscopic Surgery for T1 Glottic Lesions: A Cost-Effective Option , 1994, The Annals of otology, rhinology, and laryngology.
[19] A. Paccagnella,et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. , 1994, Journal of the National Cancer Institute.
[20] J. Tabernero,et al. Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] E. Cohen-Jonathan,et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. , 1996, International journal of radiation oncology, biology, physics.
[22] J. Califano,et al. 11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .
[23] L. Collette,et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. , 1996, Journal of the National Cancer Institute.
[24] S. Lippman,et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.
[25] W. Foulkes,et al. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study , 1996, BMJ.
[26] M. Spitz,et al. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. , 1997, Journal of the National Cancer Institute.
[27] B. Jeremic,et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] J. Quivey,et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. , 1997, International journal of radiation oncology, biology, physics.
[29] R. Day,et al. Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival , 1998 .
[30] A. Huang,et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. , 1998, The New England journal of medicine.
[31] A. Rademaker,et al. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] S. Schwartz,et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. , 1998, Journal of the National Cancer Institute.
[33] G. Pruneri,et al. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] T. Wendt,et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] R. Day,et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. , 1998, Journal of the National Cancer Institute.
[36] Jay S. Cooper,et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 , 1999 .
[37] J. Pignon,et al. Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? , 1999, Hematology/oncology clinics of North America.
[38] G. Calais,et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.
[39] E. Vokes,et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] E. Vokes,et al. How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment? , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[42] S. Glaser,et al. Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. , 2000, Critical reviews in oncology/hematology.
[43] J. Mendelsohn. Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] E. Vokes,et al. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer. , 2000, Seminars in oncology.
[45] L. Mao. Can molecular assessment improve classification of head and neck premalignancy? , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[46] Benjamin D. Smith,et al. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] R. Weichselbaum,et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] J. Bourhis,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.
[49] G. Pruneri,et al. Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes , 2000, Head & neck.
[50] B. Jeremic,et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] S. Lippman,et al. Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[52] B. Coche-Déquéant,et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma , 2000, British Journal of Cancer.
[53] A. Rademaker,et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] A. Dietz,et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.
[55] E. Vokes,et al. Locally advanced head and neck cancer , 2001, Current treatment options in oncology.
[56] Taylor Murray,et al. Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.
[57] D. Sidransky,et al. p16(MTS-1/CDKN2/INK4a) in cancer progression. , 2001, Experimental cell research.
[58] S. Warnakulasuriya. Areca nut use following migration and its consequences , 2002, Addiction biology.
[59] Q. Wei,et al. Genetic susceptibility–molecular epidemiology of head and neck cancer , 2002, Current opinion in oncology.
[60] L. Warner,et al. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. , 2014, The Cochrane database of systematic reviews.
[61] Karl Münger,et al. Human papillomavirus immortalization and transformation functions. , 2002, Virus research.
[62] E. K. Parkinson,et al. Telomerase inhibition and the future management of head-and-neck cancer. , 2002, The Lancet. Oncology.
[63] Johan Wennerberg,et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults , 2002, International journal of cancer.
[64] K. Ang,et al. Radiotherapy for cancer of the head and neck: altered fractionation regimens. , 2002, The Lancet. Oncology.
[65] C. Gwede,et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[66] P. Dulguerov,et al. Quality of life in patients with oropharynx carcinomas: Assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy , 2003, Head & neck.
[67] V. Torri,et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial. , 2003, International journal of radiation oncology, biology, physics.
[68] E. Vokes,et al. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[69] J. Ensley,et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] Iver Petersen,et al. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. , 2003, Cancer research.
[71] Jeffrey N Myers,et al. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma , 2003, Cancer.
[72] S M Bentzen,et al. Repopulation in radiation oncology: perspectives of clinical research , 2003, International journal of radiation biology.
[73] A. Argiris,et al. Epidemiology, staging, and screening of head and neck cancer. , 2003, Cancer treatment and research.
[74] B. Maciejewski,et al. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. , 2003, International journal of radiation oncology, biology, physics.
[75] R. Weber,et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. , 2003, Archives of otolaryngology--head & neck surgery.
[76] R. Weber,et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.
[77] D. Husband,et al. The treatment of early laryngeal cancers (T1–T2 N0): surgery or irradiation? , 2004, Head & neck.
[78] W. Mendenhall,et al. Management of T1–T2 glottic carcinomas , 2004, Cancer.
[79] C. Perou,et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression , 2004 .
[80] M. Spitz,et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States) , 2003, Cancer Causes & Control.
[81] G. Calais,et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] J Smith,et al. Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.
[83] E. Vokes,et al. The expanding role of systemic therapy in head and neck cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] A. Paccagnella,et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. , 2004, Journal of the National Cancer Institute.
[85] J. Jacobs,et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.
[86] K. Rufibach,et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[87] A. Rademaker,et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[88] C. Perou,et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. , 2004, Cancer cell.
[89] J. Pignon,et al. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy , 2004 .
[90] J. Pignon,et al. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[91] E. Vokes,et al. Competing Causes of Death and Second Primary Tumors in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Chemoradiotherapy , 2004, Clinical Cancer Research.
[92] E. Vokes,et al. Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancer , 2004, Head & neck.
[93] R. Ferris,et al. Elective Neck Dissection and Survival in Patients With Squamous Cell Carcinoma of the Oral Cavity and Oropharynx , 2004, The Laryngoscope.
[94] J. Wilson,et al. Cisplatinum and Bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial , 2004, Cancer Chemotherapy and Pharmacology.
[95] A. Garden,et al. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[96] L. Dawson,et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. , 2004, International journal of radiation oncology, biology, physics.
[97] Jacques Bernier,et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.
[98] R. Ferris,et al. Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and Neck , 2004, Clinical Cancer Research.
[99] R. Ferris,et al. Human leukocyte antigen (HLA) class I defects in head and neck cancer , 2005, Immunologic research.
[100] J. Bernier. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology? , 2005, Nature Clinical Practice Oncology.
[101] K. Bjordal,et al. Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study , 2005, The Laryngoscope.
[102] D. Raben,et al. New radiation therapy techniques for the treatment of head and neck cancer. , 2005, Otolaryngologic clinics of North America.
[103] C. Snyderman,et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.
[104] T. Godfrey,et al. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. , 2005, Cancer research.
[105] Napoleone Ferrara,et al. VEGF as a Therapeutic Target in Cancer , 2005, Oncology.
[106] G. Thomas,et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial , 2005, The Lancet.
[107] B. Schmidt,et al. Tongue and tonsil carcinoma , 2005, Cancer.
[108] A. Argiris. Induction chemotherapy for head and neck cancer: will history repeat itself? , 2005, Journal of the National Comprehensive Cancer Network : JNCCN.
[109] B. Murphy,et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[110] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[111] J. Shah,et al. TNM Staging of Cancers of the Head and Neck: Striving for Uniformity Among Diversity , 2005, CA: a cancer journal for clinicians.
[112] J. Carles,et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[113] M. van Glabbeke,et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.
[114] P. Wust,et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[115] S. Franceschi,et al. Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.
[116] Joseph A Califano,et al. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. , 2006, The Lancet. Oncology.
[117] Suzanne L Wolden,et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[118] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[119] P. Brennan,et al. Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. , 2006, American journal of epidemiology.
[120] J. Sterne,et al. Human papillomavirus and head and neck cancer: a systematic review and meta‐analysis , 2006, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[121] D. Heron,et al. Frameless Stereotactic Radiosurgery for Recurrent Head and Neck Carcinoma , 2006, Technology in cancer research & treatment.
[122] V. Budach,et al. Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96-3. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] S. Lippman,et al. Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia , 2006, Clinical Cancer Research.
[124] J. Bourhis,et al. Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[125] W. Mendenhall,et al. Definitive Radiotherapy for Tonsillar Squamous Cell Carcinoma , 2006, American journal of clinical oncology.
[126] Y. Nishimura,et al. Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[127] A. Shaha,et al. Tumours of familial origin in the head and neck. , 2006, Oral Oncology.
[128] P. Brennan,et al. Evidence for an Important Role of Alcohol- and Aldehyde-Metabolizing Genes in Cancers of the Upper Aerodigestive Tract , 2006, Cancer Epidemiology Biomarkers & Prevention.
[129] R. Ferris,et al. Role of Antigen-Processing Machinery in the In Vitro Resistance of Squamous Cell Carcinoma of the Head and Neck Cells to Recognition by CTL1 , 2006, The Journal of Immunology.
[130] Patrick Kemmeren,et al. Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.
[131] J. Beck,et al. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. , 2006, International journal of radiation oncology, biology, physics.
[132] Sandra Nuyts,et al. Radiation‐induced xerostomia in patients with head and neck cancer , 2006, Cancer.
[133] G. Paszkiewicz,et al. Smoking and Smokeless Tobacco-Associated Human Buccal Cell Mutations and Their Association with Oral Cancer—A Review , 2006, Cancer Epidemiology Biomarkers & Prevention.
[134] L. Mariani,et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[135] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .
[137] J. Bourhis,et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[138] A. Colevas. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[139] G. Lodi,et al. Interventions for treating oral leukoplakia. , 2006, The Cochrane database of systematic reviews.
[140] Yu Shyr,et al. Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma , 2006, Clinical Cancer Research.
[141] Avraham Eisbruch,et al. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[142] T. Yen,et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[143] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[144] Brian O'Sullivan,et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.
[145] T. Pajak,et al. Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[146] U. Duvvuri,et al. Selective Neck Dissection in Patients with Upper Aerodigestive Tract Cancer with Clinically Positive Nodal Disease , 2006, The Annals of otology, rhinology, and laryngology.
[147] B. Perez-Ordonez,et al. Molecular biology of squamous cell carcinoma of the head and neck , 2006, Journal of Clinical Pathology.
[148] H. Eich,et al. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.
[149] C. la Vecchia,et al. Body size and laryngeal cancer risk. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[150] K. Ang,et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[151] J. Lefebvre. Laryngeal preservation in head and neck cancer: multidisciplinary approach. , 2006, The Lancet. Oncology.
[152] A. Garden,et al. How to reduce radiation-related toxicity in patients with cancer of the head and neck , 2006, Current oncology reports.
[153] Petra Ambrosch,et al. Elective and therapeutic selective neck dissection. , 2006, Oral oncology.
[154] Y. Shioyama,et al. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[155] I. Angelillo,et al. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. , 2006, The American journal of clinical nutrition.
[156] M. Pepe,et al. Do erythropoietin receptors on cancer cells explain unexpected clinical findings? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[157] S. Piantadosi,et al. Advances in Brief Genetic Progression Model for Head and Neck Cancer : Implications for Field Cancerization 1 , 2006 .
[158] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[159] M. Gillison,et al. Current topics in the epidemiology of oral cavity and oropharyngeal cancers , 2007, Head & neck.
[160] T. Gorlia,et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. , 2007, The New England journal of medicine.
[161] D. Howlett,et al. "One-stop" clinics in the investigation and diagnosis of head and neck lumps. , 2007, The British journal of oral & maxillofacial surgery.
[162] M. Karamouzis,et al. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. , 2007, JAMA.
[163] A. Schueler,et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[164] J. Manola,et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. , 2007, The New England journal of medicine.
[165] B. Jeremic,et al. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. , 2007, International journal of radiation oncology, biology, physics.
[166] T. Axéll,et al. Management of oral epithelial dysplasia: a review. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[167] Carole Fakhry,et al. Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.
[168] Incidence of human papillomavirus (HPV)-related head and neck cancers in the U.S. from 1998-2003: Pre-HPV vaccine licensure , 2007 .
[169] P. Ambrosch. The role of laser microsurgery in the treatment of laryngeal cancer , 2007, Current opinion in otolaryngology & head and neck surgery.
[170] Cecelia E Schmalbach,et al. Occult primary head and neck carcinoma , 2007, Current oncology reports.
[171] A. Markoe,et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. , 2007, The New England journal of medicine.
[172] A. Armour,et al. A Phase III randomized parallel-group study of gefitinib (IRESSA) versus methotrexate (IMEX) in patients with recurrent squamous cell carcinoma of the head and neck , 2007 .
[173] W. Kendal,et al. Suicide and cancer: a gender-comparative study. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[174] K. Ang,et al. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. , 2007, International journal of radiation oncology, biology, physics.
[175] N. Hanna. Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients , 2007 .
[176] N. Hanna. Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study , 2007 .
[177] N. Hanna. Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy , 2008 .